Cargando…

Publication Rate and Characteristics of Lung Cancer Clinical Trials

This cross-sectional study estimates the publication rate of clinical trials related to lung cancer and examines the characteristics of published vs unpublished trials.

Detalles Bibliográficos
Autores principales:	Al-Shbool, Ghassan, Latif, Hira, Farid, Saira, Wang, Shuqi, Ahn, Jaeil, Giaccone, Giuseppe, Kim, Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865260/ https://www.ncbi.nlm.nih.gov/pubmed/31693119 http://dx.doi.org/10.1001/jamanetworkopen.2019.14531

Ejemplares similares

SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics
por: Al-Shbool, Ghassan, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-induced Fanconi Syndrome
por: Farid, Saira, et al.
Publicado: (2020)

Acquired Hemophilia A Presenting as Intramuscular Hematoma
por: Al-Shbool, Ghassan, et al.
Publicado: (2018)

A Systematic Review and Meta-Analysis of Clinical Characteristics and Outcomes in Patients With Lung Cancer with Coronavirus Disease 2019
por: Peravali, Monica, et al.
Publicado: (2021)

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States
por: Thomas, Anish, et al.
Publicado: (2015)

Rates of Induction of Labor at 39 Weeks and Cesarean Delivery Following Publication of the ARRIVE Trial
por: Wood, Rachel, et al.
Publicado: (2023)

Public access to protocols of contemporary cancer randomized clinical trials
por: Babu, Christopher, et al.
Publicado: (2021)

Public Health Controversies: Common Characteristics
por: Patil, Rajan R
Publicado: (2011)

Frequency of Mismatch Repair Protein (MMRP) Deficiency among Young Jordanians Diagnosed with Colorectal Carcinoma (CRC)
por: Maraqa, Bayan, et al.
Publicado: (2020)

Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives
por: Lavacchi, Daniele, et al.
Publicado: (2019)

A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
por: Kim, Chul, et al.
Publicado: (2021)

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
por: Shah, Neil J., et al.
Publicado: (2019)

E-cigarette, or Vaping, Product Use-associated Lung Injury (EVALI): Acute Lung Illness within Hours of Switching from Traditional to E-cigarettes
por: Deliwala, Smit, et al.
Publicado: (2020)

The effect of customer satisfaction on parcel delivery operations using autonomous vehicles: An agent-based simulation study
por: Shbool, Mohammad A., et al.
Publicado: (2022)

Chemo-immunotherapy as first-line treatment for small-cell lung cancer
por: Farid, Saira, et al.
Publicado: (2020)

Characteristics of COVID-19 pandemic and public health consequences
por: Stang, Andreas, et al.
Publicado: (2020)

Potential Influence of Exercise-Induced Rhabdomyolysis by Branched-Chain Amino Acid Supplementation
por: Jeon, Yong-Kyun, et al.
Publicado: (2022)

Quality assessment in gastroenterological research: publication rates of meta-analyses
por: Ramai, Daryl, et al.
Publicado: (2020)

Drugs in development for small cell lung cancer
por: Serzan, Michael T., et al.
Publicado: (2020)

Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report
por: Voortman, Jens, et al.
Publicado: (2006)

Phase I study of the (177)Lu-DOTA(0)-Tyr(3)-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
por: Kim, Chul, et al.
Publicado: (2020)

Application of condition-based maintenance for electrical generators based on statistical control charts
por: Shbool, Mohammad A., et al.
Publicado: (2023)

Hodgkin's lymphoma with cavitating lung lesion mimicking tuberculosis: A rare presentation
por: Garg, Akanksha, et al.
Publicado: (2019)

Evaluation of Publication of Pediatric Drug Trials
por: Srivastava, Ananya, et al.
Publicado: (2021)

Trial registration, publication rate and characteristics in the research field of otology: A cross-sectional study
por: van Heteren, Jan A. A., et al.
Publicado: (2019)

The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cells
por: Voortman, Jens, et al.
Publicado: (2007)

Publication Rate and Journal Review Time of COVID-19–Related Research
por: Putman, Michael S., et al.
Publicado: (2020)

Lung Cancer Risk and Low (≤50 μg/L) Drinking Water Arsenic Levels for US Counties (2009–2013)—A Negative Association
por: Lamm, Steven H., et al.
Publicado: (2018)

Public Knowledge and Attitudes Toward Clinical Trials in the COVID-19 Era
por: Patel, Eshan U., et al.
Publicado: (2022)

Global Association of the COVID-19 Pandemic With Pediatric Clinical Trial Publication
por: Grantham-Hill, Sarah, et al.
Publicado: (2023)

A Systematic Review and Meta-Regression Analysis of Lung Cancer Risk and Inorganic Arsenic in Drinking Water
por: Lamm, Steven H., et al.
Publicado: (2015)

Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials
por: Buckley, Ciara, et al.
Publicado: (2023)

Rates of Major Cardiovascular Events in Severe Asthma: U.S. Real-World and Clinical Trial–Eligible Populations
por: Dayal, Parul, et al.
Publicado: (2021)

Use of Intravesical Chemotherapy in the US Following Publication of a Randomized Clinical Trial
por: Lewicki, Patrick, et al.
Publicado: (2022)

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial
por: Akram, Javed, et al.
Publicado: (2020)

A call to encourage curricular research publications by medical students
por: Abu-Zaid, Ahmed, et al.
Publicado: (2016)

Rationale for WHO's New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results
por: Moorthy, Vasee S., et al.
Publicado: (2015)

Towards equations for estimating glomerular filtration rate without demographic characteristics
por: Peng, Hongquan, et al.
Publicado: (2022)

Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results
por: Suñé, Pilar, et al.
Publicado: (2013)

Characteristics of Open Public Hearing Speakers of the Tobacco Products Scientific Advisory Committee meetings
por: Cooper, Craig M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bo7p15c2d86nq3bp18kstm0i5b